1. Home
  2. COOK vs SAVA Comparison

COOK vs SAVA Comparison

Compare COOK & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Traeger Inc.

COOK

Traeger Inc.

HOLD

Current Price

$0.91

Market Cap

184.8M

ML Signal

HOLD

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$3.27

Market Cap

157.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COOK
SAVA
Founded
1985
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.8M
157.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
COOK
SAVA
Price
$0.91
$3.27
Analyst Decision
Hold
Buy
Analyst Count
7
2
Target Price
$2.04
$5.00
AVG Volume (30 Days)
675.8K
1.1M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$582,799,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$1.15
52 Week High
$3.31
$4.98

Technical Indicators

Market Signals
Indicator
COOK
SAVA
Relative Strength Index (RSI) 53.62 52.90
Support Level $0.71 $3.13
Resistance Level $0.84 $3.38
Average True Range (ATR) 0.09 0.22
MACD 0.01 0.05
Stochastic Oscillator 60.08 75.15

Price Performance

Historical Comparison
COOK
SAVA

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: